Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Gilbert

Showing results (1-10 of 337) with videos related to

Pageof 34
Sort By:
Statistics in Medicine|April 27, 2010
Some design issues in phase 2B vs phase 3 prevention trials for testing efficacy of products or conceptsPeter B Gilbert
Statistical Communications in Infectious Diseases|December 14, 2020
Ongoing Vaccine and Monoclonal Antibody HIV Prevention Efficacy Trials and Considerations for Sequel Efficacy Trial DesignsPeter B Gilbert
Statistical Communications in Infectious Diseases|December 15, 2010
Increasing the Efficiency of Prevention Trials by Incorporating Baseline CovariatesMin Zhang, Peter B Gilbert
Epidemiologic Methods|February 4, 2017
Predicting Overall Vaccine Efficacy in a New Setting by Re-Calibrating Baseline Covariate and Intermediate Response Endpoint Effect Modifiers of Type-Specific Vaccine EfficacyPeter B Gilbert, Ying Huang
Lifetime Data Analysis|October 30, 2015
Mark-specific hazard ratio model with missing multivariate marksMichal Juraska, Peter B Gilbert
Journal of the Royal Statistical Society. Series C, Applied Statistics|February 3, 2015
Inferences on relative failure rates in stratified mark-specific proportional hazards models with missing marks, with application to HIV vaccine efficacy trialsPeter B Gilbert, Yanqing Sun
Biometrics|April 27, 2011
Comparing biomarkers as principal surrogate endpointsYing Huang, Peter B Gilbert
Scandinavian Journal of Statistics, Theory and Applications|March 23, 2013
Estimation of Stratified Mark-Specific Proportional Hazards Models with Missing MarksYanqing Sun, Peter B Gilbert
Biometrics|December 24, 2002
Flexible weighted log-rank tests optimal for detecting early and/or late survival differencesLang Wu, Peter B Gilbert
Biostatistics (Oxford, England)|October 10, 2009
Semiparametric estimation of the average causal effect of treatment on an outcome measured after a postrandomization event, with missing outcome dataPeter B Gilbert, Yuying Jin
Pageof 34

Showing results (1-10 of 337) with videos related to

Sort By:
Pageof 34
Statistics in Medicine|April 27, 2010
Some design issues in phase 2B vs phase 3 prevention trials for testing efficacy of products or conceptsPeter B Gilbert
Statistical Communications in Infectious Diseases|December 14, 2020
Ongoing Vaccine and Monoclonal Antibody HIV Prevention Efficacy Trials and Considerations for Sequel Efficacy Trial DesignsPeter B Gilbert
Statistical Communications in Infectious Diseases|December 15, 2010
Increasing the Efficiency of Prevention Trials by Incorporating Baseline CovariatesMin Zhang, Peter B Gilbert
Epidemiologic Methods|February 4, 2017
Predicting Overall Vaccine Efficacy in a New Setting by Re-Calibrating Baseline Covariate and Intermediate Response Endpoint Effect Modifiers of Type-Specific Vaccine EfficacyPeter B Gilbert, Ying Huang
Lifetime Data Analysis|October 30, 2015
Mark-specific hazard ratio model with missing multivariate marksMichal Juraska, Peter B Gilbert
Journal of the Royal Statistical Society. Series C, Applied Statistics|February 3, 2015
Inferences on relative failure rates in stratified mark-specific proportional hazards models with missing marks, with application to HIV vaccine efficacy trialsPeter B Gilbert, Yanqing Sun
Biometrics|April 27, 2011
Comparing biomarkers as principal surrogate endpointsYing Huang, Peter B Gilbert
Scandinavian Journal of Statistics, Theory and Applications|March 23, 2013
Estimation of Stratified Mark-Specific Proportional Hazards Models with Missing MarksYanqing Sun, Peter B Gilbert
Biometrics|December 24, 2002
Flexible weighted log-rank tests optimal for detecting early and/or late survival differencesLang Wu, Peter B Gilbert
Biostatistics (Oxford, England)|October 10, 2009
Semiparametric estimation of the average causal effect of treatment on an outcome measured after a postrandomization event, with missing outcome dataPeter B Gilbert, Yuying Jin
Pageof 34